Related Experiment Video
Updated: Dec 18, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su1, Lei Dong1, Yangchan Li2
1Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA 91016, USA.
Abstract:
Fat mass and obesity-associated protein (FTO), an RNA N6-methyladenosine (m6A) demethylase, plays oncogenic roles in various cancers, presenting an opportunity for the development of effective targeted therapeutics. Here, we report two potent small-molecule FTO inhibitors that exhibit strong anti-tumor effects in multiple types of cancers. We show that genetic depletion and pharmacological inhibition of FTO dramatically attenuate leukemia stem/initiating cell self-renewal and reprogram immune response by suppressing expression of immune checkpoint genes, especially LILRB4. FTO inhibition sensitizes leukemia cells to T cell cytotoxicity and overcomes hypomethylating agent-induced immune evasion. Our study demonstrates that FTO plays critical roles in cancer stem cell self-renewal and immune evasion and highlights the broad potential of targeting FTO for cancer therapy.
Insights
Fat mass and obesity-associated protein (FTO) inhibitors show potent anti-tumor effects. Targeting FTO suppresses cancer stem cell self-renewal and enhances immune response, offering new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Fat mass and obesity-associated protein (FTO) is an RNA demethylase implicated in oncogenesis.
- FTO's role in cancer presents a target for novel therapeutics.
Purpose of the Study:
- To develop and evaluate small-molecule FTO inhibitors for cancer therapy.
- To investigate the impact of FTO inhibition on cancer stem cell self-renewal and immune response.
Main Methods:
- Development of two potent small-molecule FTO inhibitors.
- Assessment of anti-tumor effects in various cancer types.
- Genetic and pharmacological FTO inhibition in leukemia models.
- Analysis of immune checkpoint gene expression and T cell cytotoxicity.
Main Results:
- FTO inhibitors demonstrated significant anti-tumor activity across multiple cancer types.
- FTO inhibition reduced leukemia stem/initiating cell self-renewal.
- FTO suppression reprogrammed immune response by downregulating immune checkpoint genes, notably LILRB4.
- FTO inhibition sensitized leukemia cells to T cell-mediated killing and overcame immune evasion.
Conclusions:
- FTO plays a crucial role in cancer stem cell self-renewal and immune evasion.
- Targeting FTO with small-molecule inhibitors offers a promising therapeutic strategy for various cancers, particularly leukemia.
- FTO inhibition can enhance anti-cancer immunity and overcome treatment resistance.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Replicative Cell Senescence